Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
ACS Omega ; 6(31): 20455-20470, 2021 Aug 10.
Article in English | MEDLINE | ID: mdl-34395993

ABSTRACT

There is a significant need for new agents to combat malaria, which resulted in ∼409,000 deaths globally in 2019. We utilized a ring distortion strategy to create complex and diverse compounds from vincamine with the goal of discovering molecules with re-engineered biological activities. We found compound 8 (V3b) to target chloroquine-resistant Plasmodium falciparum Dd2 parasites (EC50 = 1.81 ± 0.09 µM against Dd2 parasites; EC50 > 40 µM against HepG2 cells) and established structure-activity relationships for 25 related analogues. New analogue 30 (V3ss, Dd2, EC50 = 0.25 ± 0.004 µM; HepG2, EC50 > 25 µM) was found to demonstrate the most potent activity, which prevents exit on the parasite from the schizont stage of intraerythrocytic development and requires >24 h to kill P. falciparum Dd2 cells. These findings demonstrate the potential that vincamine ring distortion has toward the discovery of novel antimalarial agents and other therapies significant to human health.

2.
ACS Infect Dis ; 6(2): 159-167, 2020 02 14.
Article in English | MEDLINE | ID: mdl-31913597

ABSTRACT

Select natural products are ideal starting points for ring distortion, or the dramatic altering of inherently complex molecules through short synthetic pathways, to generate an array of novel compounds with diverse skeletal architectures. A major goal of our ring distortion approach is to re-engineer the biological activity of indole alkaloids to identify new compounds with diverse biological activities in areas of significance to human health and medicine. In this study, we re-engineered the biological activity of the indole alkaloid yohimbine through ring rearrangement and ring cleavage synthesis pathways to discover new series of antiplasmodial agents. One new compound, Y7j, was found to demonstrate good potency against chloroquine-resistant Plasmodium falciparum Dd2 cells (EC50 = 0.33 µM) without eliciting cytotoxicity against HepG2 cells (EC50 > 40 µM). Y7j demonstrated stage-specific action against parasites at the late ring/trophozoite stage. A series of analogues was synthesized to gain structure-activity relationship insights, and we learned that both benzyl groups of Y7j are required for activity and fine-tuning of antiplasmodial activities could be accomplished by changing substitution patterns on the benzyl moieties. This study demonstrates the potential for ring distortion to drive new discoveries and change paradigms in chemical biology and drug discovery.


Subject(s)
Antimalarials/chemistry , Antimalarials/pharmacology , Biological Products/pharmacology , Drug Discovery , Plasmodium falciparum/drug effects , Yohimbine/chemistry , Yohimbine/pharmacology , Biological Products/chemistry , Chloroquine/pharmacology , Drug Resistance , Hep G2 Cells , Humans , Indole Alkaloids/chemistry , Indole Alkaloids/pharmacology , Malaria/drug therapy , Malaria/parasitology , Molecular Structure , Parasitic Sensitivity Tests , Structure-Activity Relationship , Trophozoites/drug effects
3.
Molecules ; 24(6)2019 Mar 20.
Article in English | MEDLINE | ID: mdl-30897744

ABSTRACT

The screening of more than 30 million compounds derived from 81 small molecule libraries built on 81 distinct scaffolds identified pyrrolidine bis-cyclic guanidine library (TPI-1955) to be one of the most active and selective antiplasmodial libraries. The screening of the positional scanning library TPI-1955 arranged on four sets of sublibraries (26 + 26 + 26 + 40), totaling 120 samples for testing provided information about the most important groups of each variable position in the TPI-1955 library containing 738,192 unique compounds. The parallel synthesis of the individual compounds derived from the deconvolution of the positional scanning library led to the identification of active selective antiplasmodial pyrrolidine bis-cyclic guanidines.


Subject(s)
Antimalarials/therapeutic use , Guanidines/chemistry , Animals , Combinatorial Chemistry Techniques , Malaria/drug therapy , Mice , Plasmodium/drug effects , Solid-Phase Synthesis Techniques/methods
SELECTION OF CITATIONS
SEARCH DETAIL
...